Home › Uveal Melanoma › New York
Uveal Melanoma clinical trials in New York
7 studies for Uveal Melanoma are looking for participants at sites in New York.
Cities in New York
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT05607095Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma
- Memorial Sloan Kettering Cancer Center, New York
- Northwell Health, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07804186Adjuvant Tebentafusp in High Risk Ocular Melanoma
- Northwell Health -Center for Advanced Medicine, Lake Success
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 30, 2026 · NCT06246149ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 13, 2026 · NCT03686124Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center - 1275 York Ave, New York
- Northwell Health Cancer Institute, New York
RecruitingPhase 3
Ages 18 and older · All sexes · Updated May 6, 2026 · NCT07015190A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2/3
All ages · All sexes · Updated Apr 2, 2026 · NCT06581406Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
- Northwell Health Center for Advanced Medicine, New Hyde Park
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Dec 4, 2025 · NCT06121180From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.